Literature DB >> 3640782

Acquired C1 esterase-inhibitor deficiency: case report with emphasis on complement and kallikrein activation during two patterns of clinical manifestations.

F Hentges, R Humbel, M Dicato, R Hemmer, H Kuntziger.   

Abstract

A case of severe angioedema with several episodes of life-threatening attacks during a follow-up of 7 years is presented. Although the biologic profile is that of an acquired C1 INH deficiency, no lymphoproliferative malignancy or immune-complex disease could be proven until now. However, the patient has had a small monoclonal IgG lambda-gammopathy for 4 years. During the last 4 years, edematous manifestations have stopped. The patient now suffers at regular intervals of about a week from short-lasting attacks with digestive and vasomotor symptoms. This clinical evolution is accompanied by a worsening in the complement abnormalities. The digestive and vasomotor attacks were found to be correlated with sudden prekallikrein and high-molecular-weight kininogen consumption. These findings demonstrate that prekallikrein is activated during acquired C1 INH deficiency and that the products of this pathway such as bradykinin are probably responsible for a part of the clinical manifestations associated with this disorder.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3640782     DOI: 10.1016/0091-6749(86)90231-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

1.  Hereditary angioedema (HAE): a cause for recurrent abdominal pain.

Authors:  Parita Soni; Vivek Kumar; Samson Alliu; Vijay Shetty
Journal:  BMJ Case Rep       Date:  2016-11-14

Review 2.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

3.  Proteolytic inactivation of plasma C1- inhibitor in sepsis.

Authors:  J H Nuijens; A J Eerenberg-Belmer; C C Huijbregts; W O Schreuder; R J Felt-Bersma; J J Abbink; L G Thijs; C E Hack
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system.

Authors:  S Nakamura; M Yoshinari; Y Saku; K Hirakawa; C Miishima; K Murai; K Tokiyama; M Fujishima
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.